Acelity

Last updated
Acelity, L.P. Inc.
TypeSubsidiary of 3M
Industry Medical equipment
Founded1976
FateSubsidiary
Headquarters
San Antonio, Texas
Website acelity.com

Acelity L.P. Inc., was a privately held medical device company. It was a non-operating holding company whose wholly owned subsidiaries developed advanced wound therapeutics products. The advanced wound therapeutics business was conducted by Kinetic Concepts, Inc. (KCI) and its subsidiaries, including Systagenix. [1]

Contents

The company reported $1.87 billion in annual revenue globally in 2015. [2]

In October 2019 Acelity Inc. and its KCI subsidiaries worldwide were acquired by 3M. [3]

History

Acelity began as Kinetic Concepts Inc., a medical technology company founded in 1976 by Dr. Jim Leininger, an emergency room physician in San Antonio, Texas. [4] Over time, the company developed or acquired a line of therapeutic specialty beds, introducing a specialty bed for acute care patients with pulmonary complications. [5] Initially KCI's product development focused on therapeutic beds and surfaces then expanded to introduce V.A.C. Therapy, the first commercial negative pressure wound therapy products in the mid-1990s. In 2016, more than 10 million wounds were treated with V.A.C. Therapy worldwide since its introduction. [6] [7] [8] In 2008, KCI acquired LifeCell, a company specializing in regenerative medicine, in a non-hostile transaction for US$1.7 billion. [9] [10] [11] In October 2013, KCI acquired Systagenix Wound Management, originally Johnson & Johnson's professional wound care business for $485 million. [12] In September 2014, KCI's parent company announced that KCI, LifeCell and Systagenix would operate under one global medical technology brand known as Acelity. [13] On December 21, 2016, pharmaceutical company Allergan announced it would acquire LifeCell Corp. for US$2.9 billion. [14] The sale completed on February 1, 2017. [15]

In April 2017, Acelity announced R. Andrew Eckert would replace Joseph Woody as chief executive and president. [16]

Financial information

From the founding of KCI in 1976 to 1988, the revenue of KCI grew to US$153.2 million. The growth in revenue allowed KCI to go public and trade on the New York Stock Exchange (NYSE) for the first time in 1988. [17] KCI stock was traded on the NYSE until 1997, when the company went private. In February 2004, KCI became a publicly listed company for the second time and was listed on the NYSE under the ticker symbol KCI. [18] [19] By the late 2000s, the company's revenue was over $1 billion and reported an increase of 17 percent in 2007 to $1.61 billion. [20] Revenue for 2008 was $1.88 billion, increasing to $1.99 billion in 2009 [21] and in 2010 increased to $2.02 billion. [22] In 2011, the company went private again at a price of $68.50 per share. In August 2015, Acelity filed a registration statement on Form S-1 with the US Securities and Exchange Commission relating to a proposed initial offering of its common stock. [23] On December 7, 2016, the company withdrew its IPO registration statement with the SEC, citing a challenging IPO market. [24]

Mergers and acquisitions

Early 1990s: KCI detailed its operations into four divisions: [25] KCI New Technologies, Inc. (Nutech—organized in 1992 focused on lower-cost technologies), KCI Home Care (organized in 1995 focused on selling wholesale to home medical equipment providers), KCI Therapeutic Services, Inc. (KCTS—rented specialty beds to patients or to hospitals), and KCI International (KCII—organized in 1991 focused on providing the services and products of KCI to foreign countries, including most of Western Europe, Scandinavia, and Australia).

1990: KCI purchased Medirec [26] for $26 million in cash and $10 million in KCI securities, forming KCI's Medical Services Division. KCI later sold KCI Medical Services [25] in September 1994 for $65.3 million in cash and $18.8 million in promissory notes.

1991: KCI purchased Mediscus International, a British competitor in the specialty bed business. The transaction brought KCI products into 10 countries and formed the KCI International subsidiary.[ citation needed ]

1996: KCI purchased U.K.-based Astec Medical Ltd. [27] The acquisition added four new products to KCI International's product line and allowed KCI to expand its market share in the U.K. community segment.

1997: KCI acquired the Ethos Medical Group. [28] Later that year, Equitron Manufacturing was acquired, adding bariatric products to the Home Care offerings at KCI.[ citation needed ]

1998: KCI USA was formed as a result of the merger between KCI's New Technologies (NuTech) with KCI Therapeutic Services. The merger united the sales and marketing operations of the two divisions.[ citation needed ]

2008: KCI acquired LifeCell, a company specializing in regenerative medicine, in a non-hostile transaction for US$1.7 billion. [29]

2013: KCI acquired Systagenix Wound Management, formerly Johnson & Johnson's professional wound care business, for $485 million. [30]

2014: KCI's parent company announced that KCI, LifeCell and Systagenix would operate under one global medical technology brand known as Acelity. [31] That same year, Acelity acquired exclusive worldwide rights from the GID Group, Inc. to develop, manufacture and commercialize the REVOLVE System, [32] a fat processing technology used in both reconstructive and cosmetic procedures to facilitate high-volume, autologous fat grafting. LifeCell previously held exclusive rights to distribute the REVOLVE System in the US and Canada since 2013.

2015: Acelity acquired the SNAP business from Spiracur, Inc. [33]

2016: On December 20, Acelity announced a definitive agreement with Allergan for the acquisition of the company's LifeCell business unit for $2.9 billion in cash. [34]

2017: Acelity completed the sale of LifeCell to Allergan for $2.9 billion in cash on February 1. [35]

2019: Acelity and its KCI subsidiaries worldwide were acquired by 3M for $6.7 billion, including assumption of debt and other adjustments. [36]

Related Research Articles

<span class="mw-page-title-main">Agilent Technologies</span> American technology company

Agilent Technologies, Inc. is a global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting IPO of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.

<span class="mw-page-title-main">GE HealthCare</span> American multinational medical technology company

GE HealthCare Technologies, Inc., doing business as GE HealthCare, is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from General Electric on January 4, 2023, with GE retaining 13.5%. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, XRAY; Ultrasound; Cath Labs; Mammogram; Nuclear Medicine Cameras; and develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries.

<span class="mw-page-title-main">Ethicon</span> Pharmaceutical company

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line.

Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.

<span class="mw-page-title-main">Allergan, Inc.</span> Former American conglomerate

Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. It ceased operation in 2015 when it was acquired by Irish-based Actavis plc, who then renamed the group as Allergan plc.

Siemens Healthineers is a German company which provides healthcare solutions and services. It was spun off from its parent company Siemens in 2017, which retains a 75% stake. Siemens Healthineers is the parent company for several medical technology companies and is headquartered in Erlangen, Germany.

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed briefly by US-based Pfizer. Teva regained its market leader position once Pfizer spun off its generic drug division in a merger with Mylan, forming the new company Viatris at the end of 2020. Overall, Teva is the 18th largest pharmaceutical company in the world.

<span class="mw-page-title-main">Actavis</span> Global pharmaceutical company

Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.

<span class="mw-page-title-main">3M</span> American multinational corporation

3M Company is an American multinational conglomerate operating in the fields of industry, worker safety, healthcare, and consumer goods. The company produces over 60,000 products under several brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software, and optical films. It is based in Maplewood, a suburb of Saint Paul, Minnesota.

Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson and is composed of two divisions, Johnson & Johnson Surgical Vision and Johnson & Johnson Vision Care. Services include Intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastic, Microkeratomes and related products used in cataract and refractive surgery.

<span class="mw-page-title-main">Thermo Fisher Scientific</span> Provisioner of scientific consumables, equipment, and services

Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).

Terumo Corporation was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan.

<span class="mw-page-title-main">Kinetic Concepts</span>

Kinetic Concepts, Inc., (KCI) is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. In 2013, the company employed 5,000 people and marketed its products in more than 25 countries. Its headquarters is in San Antonio, Texas.

Calera Capital is a private equity firm focused on investments in middle-market companies. Founded in 1991, the firm is currently investing out of its fifth fund, Calera Capital Partners V, which was raised in 2017. Calera Capital has offices in San Francisco and Boston.

CareFusion was a medical company specializing in two areas: reducing medication errors and prevention of health care-associated infections.

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira (adalimumab), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

<span class="mw-page-title-main">Zoetis</span> American animal health company

Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.

<span class="mw-page-title-main">Editas Medicine</span> Discovery-phase pharmaceutical company

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Brent Saunders is an American biopharma executive, entrepreneur, and chief executive officer and chairman of eye health company Bausch & Lomb. He is helped lead various mergers and acquisitions and overseen the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.

References

  1. ↑ "2014 Q3 10Q". www.sec.gov. Retrieved 2020-09-11.
  2. ↑ Bailey, W. Scott (January 27, 2016). "San Antonio's Acelity showing signs of progress". San Antonio Business Journal.
  3. ↑ "3M Completes Acquisition of Acelity, Inc". 3M News | United States. Archived from the original on 2019-10-19. Retrieved 2019-10-19.
  4. ↑ Kinetic Concepts Inc. Implements SolidWorks Software as Company-Wide Engineering Standard.” Business Wire. 6 March 2000
  5. ↑ Kinetic Concepts introduces TriaDyne, latest addition to line of therapeutic beds and surfaces". Business Wire. 23 May 1995.
  6. ↑ Talaat, Sarah (August 9, 2016). "Homegrown Biotech Company Aims to Disrupt Wound Care Market". therivardreport.com. Retrieved 2017-11-14.
  7. ↑ Benesh, Peter (14 June 2004). "Second IPO Helps Heal Old Wounds; Kinetic Concepts Inc.; San Antonio, Texas". Investor's Business Daily. p. A09.
  8. ↑ KCI Honors Dr. Louis Argenta With Research-Based Fellowship and Scholarship". Business Wire. 12 October 2009.
  9. ↑ "KCI earnings up during second quarter". San Antonio Business Journal. July 21, 2009. Archived from the original on 2012-11-02. Retrieved 2017-11-14.
  10. ↑ KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader". Business Wire. 7 April 2008.
  11. ↑ Analyst questions Kinetic Concepts' purchase of LifeCell due to high price and low revenue". The Associated Press. 8 April 2008.
  12. ↑ Danner, Patrick (July 30, 2013). "KCI buying Systagenix for $485M". San Antonio Express-News. Retrieved 2017-11-14.
  13. ↑ Bailey, W. Scott (September 3, 2014). "KCI parent company remaking itself as Acelity". San Antonio Business Journal. Archived from the original on 2014-09-05. Retrieved 2017-11-14.
  14. ↑ Helfand, Carly (21 December 2016). "Acquisitive Allergan gets top-line help, cost-savings potential with $2.9B LifeCell buy - FiercePharma". Archived from the original on 2016-12-22.
  15. ↑ Danner, Patrick (2017-02-01). "S.A.-based Acelity completes $2.9B sale to pharma giant Allergan". Express News. Archived from the original on 2017-02-08. Retrieved 2020-09-11.
  16. ↑ "San Antonio's Acelity names new CEO". San Antonio Express-News. Retrieved 2017-04-05.
  17. ↑ Blaker, Ashley (24 December 1990). "Kinetic Expands Foreign Presence With Acquisitions". San Antonio Business Journal 4 (49): 1.
  18. ↑ Benesh, Peter (14 June 2004). "Second IPO Helps Heal Old Wounds; Kinetic Concepts Inc.; San Antonio, Texas". Investor's Business Daily. p. A09.
  19. ↑ Berko, Malcolm (3 August 2007). "Wound-care developer is a healthy company". Copley News Service.
  20. ↑ KCI concludes 2007 on strong note. San Antonio Business Journal. 29 January 2008.
  21. ↑ Highlights KCI. MSN Money. MSN. January 2011. Retrieved 25 January 2011.
  22. ↑ Kinetic Concepts 4Q profit grows 12 percent. Bloomberg Business News. Associated Press. 1 February 2011. Retrieved 4 February 2011.
  23. ↑ "Acelity Aims for Massive IPO – 24/7 Wall St" . Retrieved 2020-09-11.
  24. ↑ Bailey, W. Scott (8 December 2016). "SA-based global biotech company halts plans to launch IPO". San Antonio Business Journal. Archived from the original on 2016-12-15.
  25. 1 2 Poling, Travis (23 June 1996). "KCI shopping the market for the right acquisition opportunity". San Antonio Business Journal. Archived from the original on 2017-01-05.
  26. ↑ "TEXAS FIRM ACQUIRES MEDIREC". Deseret News. 1990-08-05. Retrieved 2020-09-11.
  27. ↑ "SEC Info - Kinetic Concepts Inc - '10-K' for 12/31/96 - EX-13". SEC Info. Archived from the original on 2017-01-05. Retrieved 2020-09-11.
  28. ↑ "KCI Subsidiaries". www.sec.gov. Retrieved 2023-10-31.
  29. ↑ KCI to Acquire LifeCell for $1.7 Billion in Cash Creating a Global Medical Technology Leader. Business Wire. 7 April 2008
  30. ↑ Danner, Patrick (2013-07-30). "KCI buying Systagenix for $485M". San Antonio Express-News. Retrieved 2020-09-11.
  31. ↑ Bailey, W. Scott (3 September 2014). "KCI parent company remaking itself as Acelity". San Antonio Business Journal. Archived from the original on 2014-09-05.
  32. ↑ Mann, Denise (2014-11-20). "Acelity Scoops Up Worldwide Rights for REVOLVE Fat Grafting System". Plastic Surgery Practice. Retrieved 2020-09-11.
  33. ↑ Bailey, W. Scott (1 December 2015). "Acelity acquires wound-care technology from California company". San Antonio Business Journal. Archived from the original on 2017-01-05.
  34. ↑ "Allergan to buy Acelity's tissue unit LifeCell for $2.9 billion". Reuters. 2016-12-20. Retrieved 2020-09-11.
  35. ↑ "Allergan closes $3B Acelity LifeCell buy". MassDevice. 2017-02-01. Retrieved 2020-09-11.
  36. ↑ "3M Completes Acquisition of Acelity, Inc". 3M News | United States. Archived from the original on 2019-10-19. Retrieved 2019-10-19.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.